$3.06 EPS Expected for HCA Healthcare Inc (NYSE:HCA) This Quarter

Equities research analysts expect that HCA Healthcare Inc (NYSE:HCA) will announce earnings per share of $3.06 for the current quarter, according to Zacks Investment Research. Nine analysts have issued estimates for HCA Healthcare’s earnings. The highest EPS estimate is $3.19 and the lowest is $2.96. HCA Healthcare posted earnings per share of $2.99 in the same quarter last year, which indicates a positive year over year growth rate of 2.3%. The business is scheduled to issue its next earnings results before the market opens on Tuesday, January 28th.

On average, analysts expect that HCA Healthcare will report full-year earnings of $10.53 per share for the current fiscal year, with EPS estimates ranging from $10.45 to $10.60. For the next financial year, analysts forecast that the company will report earnings of $11.63 per share, with EPS estimates ranging from $11.39 to $11.85. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side research firms that follow HCA Healthcare.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $2.23 EPS for the quarter, beating the Zacks’ consensus estimate of $2.13 by $0.10. HCA Healthcare had a net margin of 6.98% and a negative return on equity of 173.49%. The company had revenue of $12.69 billion for the quarter, compared to analyst estimates of $12.48 billion. During the same period in the prior year, the firm posted $2.16 EPS. The company’s quarterly revenue was up 10.9% on a year-over-year basis.

A number of brokerages have commented on HCA. JPMorgan Chase & Co. upped their price target on shares of HCA Healthcare from $157.00 to $186.00 and gave the company an “overweight” rating in a research report on Friday, December 20th. Deutsche Bank began coverage on HCA Healthcare in a report on Friday, January 3rd. They set a “buy” rating and a $140.00 price target for the company. Bank of America raised HCA Healthcare from a “neutral” rating to a “buy” rating in a research report on Friday, December 6th. Barclays boosted their price objective on HCA Healthcare from $145.00 to $155.00 and gave the company an “overweight” rating in a research note on Wednesday, October 30th. Finally, ValuEngine upgraded HCA Healthcare from a “sell” rating to a “hold” rating in a research report on Wednesday, October 2nd. Two equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $156.07.

NYSE HCA traded up $0.63 during mid-day trading on Friday, reaching $148.40. 1,685,432 shares of the stock were exchanged, compared to its average volume of 970,363. The stock has a market cap of $50.12 billion, a P/E ratio of 14.85, a P/E/G ratio of 1.13 and a beta of 0.92. HCA Healthcare has a one year low of $110.31 and a one year high of $150.17. The stock has a 50 day simple moving average of $145.59 and a 200-day simple moving average of $133.43.

The business also recently declared a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Monday, December 2nd were paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 1.08%. The ex-dividend date was Friday, November 29th. HCA Healthcare’s dividend payout ratio (DPR) is currently 16.38%.

In other news, insider Jon M. Foster sold 19,477 shares of the firm’s stock in a transaction dated Thursday, October 31st. The stock was sold at an average price of $132.35, for a total value of $2,577,780.95. Following the completion of the sale, the insider now directly owns 10,015 shares in the company, valued at approximately $1,325,485.25. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Deborah M. Reiner sold 749 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $136.67, for a total value of $102,365.83. Following the completion of the sale, the senior vice president now owns 8,237 shares of the company’s stock, valued at $1,125,750.79. The disclosure for this sale can be found here. Insiders have sold 48,511 shares of company stock worth $6,592,095 in the last quarter. Company insiders own 2.70% of the company’s stock.

A number of hedge funds have recently bought and sold shares of the stock. Schroder Investment Management Group lifted its holdings in HCA Healthcare by 215.7% in the 2nd quarter. Schroder Investment Management Group now owns 1,328,422 shares of the company’s stock valued at $179,562,000 after purchasing an additional 907,658 shares in the last quarter. Jacobs Levy Equity Management Inc. lifted its holdings in shares of HCA Healthcare by 11.4% during the 2nd quarter. Jacobs Levy Equity Management Inc. now owns 12,260 shares of the company’s stock valued at $1,657,000 after purchasing an additional 1,250 shares in the last quarter. Johnson Investment Counsel Inc. lifted its stake in HCA Healthcare by 70.6% in the 2nd quarter. Johnson Investment Counsel Inc. now owns 4,156 shares of the company’s stock valued at $561,000 after acquiring an additional 1,720 shares in the last quarter. Private Advisor Group LLC lifted its stake in HCA Healthcare by 38.9% in the 2nd quarter. Private Advisor Group LLC now owns 2,245 shares of the company’s stock valued at $304,000 after acquiring an additional 629 shares in the last quarter. Finally, Ellington Management Group LLC bought a new stake in HCA Healthcare in the 2nd quarter valued at approximately $284,000. 69.43% of the stock is currently owned by institutional investors and hedge funds.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

See Also: How to Invest in an Index Fund

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.